Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Meningococcal – Research Paper
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
Javier Díez-Domingoa Vaccine Research Area, FISABIO-Public Health, Valencia, Spain
https://orcid.org/0000-0003-1008-3922View further author information
https://orcid.org/0000-0003-1008-3922View further author information, , , , , Ignacio Salamanca de la Cuevaf Instituto Hispalense de Pediatria, Seville, Spainhttps://orcid.org/0000-0003-0561-9913View further author information
https://orcid.org/0000-0003-0561-9913View further author information, , Edson Duarte Moreira Jr.h Associação Obras Sociais Irmã Dulce and Oswaldo Cruz Foundation, Brazilian Ministry of Health, Salvador, Brazilhttps://orcid.org/0000-0002-7081-8348View further author information
https://orcid.org/0000-0002-7081-8348View further author information, , , , , , , Marco Costantinin Biostatistics, GSK, Siena, Italyhttps://orcid.org/0000-0003-4709-2590View further author information
https://orcid.org/0000-0003-4709-2590View further author information, , , , , , , Juan-Antonio García-Martínezu Medical Department, GSK, Madrid, Spainhttps://orcid.org/0000-0001-5330-6343View further author information
https://orcid.org/0000-0001-5330-6343View further author information, Venere Basilev Global Clinical Delivery, Global Clinical Operations Development, GSK, Siena, Italyhttps://orcid.org/0000-0002-7475-7749View further author information
https://orcid.org/0000-0002-7475-7749View further author information, , Maria Lattanzim Clinical Research and Development Centre, GSK, Siena, Italyhttps://orcid.org/0000-0002-3457-426XView further author information
https://orcid.org/0000-0002-3457-426XView further author information & Michele Pellegrinim Clinical Research and Development Centre, GSK, Siena, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-8505-9260View further author information
https://orcid.org/0000-0001-8505-9260View further author information show all